Sales of annuities have been booming in recent years. According to InsuranceNewsNet, "in the first nine months of 2024, total ...

These are unquestionably serious issues, but Merck remains a top stock to buy and hold, at least for investors focused on the long game. Here's why. Merck's Keytruda generates over $20 billion in ...